A Single-Dose Study of MT-201 and Concomitant Infliximab in Healthy Participants

Clinical trial NCT07776782 · RECRUITING

Trial details

NCT number: NCT07776782
Sponsor: Mirador Therapeutics, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Volunteer

Start date: 2026-07-16
Primary completion: 2026-11-12
Enrollment: 25

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.